Bryn Mawr Trust CO Charles River Laboratories International, Inc. Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 209 shares of CRL stock, worth $34,232. This represents 0.0% of its overall portfolio holdings.
Number of Shares
209
Previous 300
30.33%
Holding current value
$34,232
Previous $59,000
35.59%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
51.8MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$999 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$833 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$613 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$349 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$318 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.33B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...